Supplementary Table 1 from Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms

Abstract

<p>Table S1. Clinical information of the 46 AML patients who provided AML cells for in vitro or in vivo assays.</p>